Literature DB >> 18807012

Severe weakness complicating status asthmaticus despite minimal duration of neuromuscular paralysis.

Sarah M Kesler1, Mark D Sprenkle, William S David, James W Leatherman.   

Abstract

OBJECTIVE: Mechanically ventilated patients with status asthmaticus who undergo prolonged paralysis are at risk for severe weakness due to myopathy. In the mid-1990s, we changed our usual method of achieving tolerance of ventilatory support in asthmatic patients from continuous paralysis to deep sedation. This study examines the impact of this change in practice on the development of clinically significant weakness in status asthmaticus. DESIGN AND
SETTING: Retrospective cohort study in university-affiliated county hospital. PATIENTS: Mechanically ventilated asthmatic patients seen before (n = 96) and after (n = 74) a clinical practice change in 1995 that markedly restricted use of paralytics.
RESULTS: The duration of neuromuscular paralysis declined sharply after 1995 (23.7 +/- 42.2 vs. 1.8 +/- 4.0 h, P < 0.001), but this was not associated with a significant difference in the incidence of weakness (21 vs. 14%, P = 0.23). Within the post-1995 cohort, there was no significant difference in the duration of paralysis for weak and non-weak patients (3.5 +/- 6.2 vs. 1.5 +/- 3.5 h, P = 0.10). However, weak patients had a much longer duration of mechanical ventilation than did patients without weakness (11.9 +/- 3.6 vs. 1.9 +/- 1.8 days, P < 0.001).
CONCLUSION: Mechanically ventilated patients with status asthmaticus who are immobilized for prolonged periods of time by deep sedation remain at risk for clinically significant weakness.

Entities:  

Mesh:

Year:  2008        PMID: 18807012     DOI: 10.1007/s00134-008-1267-5

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  18 in total

1.  Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment.

Authors:  M J Danon; S Carpenter
Journal:  Muscle Nerve       Date:  1991-11       Impact factor: 3.217

2.  Acute myopathy in severe acute asthma treated with intravenously administered corticosteroids.

Authors:  T J Williams; R E O'Hehir; D Czarny; M Horne; G Bowes
Journal:  Am Rev Respir Dis       Date:  1988-02

3.  Risk factors for hydrocortisone myopathy in acute severe asthma.

Authors:  C D Shee
Journal:  Respir Med       Date:  1990-05       Impact factor: 3.415

Review 4.  Acute weakness syndromes in critically ill patients--a reappraisal.

Authors:  J L Nates; D J Cooper; B Day; D V Tuxen
Journal:  Anaesth Intensive Care       Date:  1997-10       Impact factor: 1.669

5.  Myopathy following mechanical ventilation for acute severe asthma: the role of muscle relaxants and corticosteroids.

Authors:  N A Behbehani; F Al-Mane; Y D'yachkova; P Paré; J M FitzGerald
Journal:  Chest       Date:  1999-06       Impact factor: 9.410

6.  Respiratory weakness is associated with limb weakness and delayed weaning in critical illness.

Authors:  Bernard De Jonghe; Sylvie Bastuji-Garin; Marie-Christine Durand; Isabelle Malissin; Pablo Rodrigues; Charles Cerf; Hervé Outin; Tarek Sharshar
Journal:  Crit Care Med       Date:  2007-09       Impact factor: 7.598

7.  EMG findings in acute myopathy with status asthmaticus, steroids and paralytics. Clinical and electrophysiologic correlation.

Authors:  W S David; C L Roehr; J W Leatherman
Journal:  Electromyogr Clin Neurophysiol       Date:  1998-09

8.  Daily interruption of sedative infusions and complications of critical illness in mechanically ventilated patients.

Authors:  William D Schweickert; Brian K Gehlbach; Anne S Pohlman; Jesse B Hall; John P Kress
Journal:  Crit Care Med       Date:  2004-06       Impact factor: 7.598

9.  Myopathy in severe asthma.

Authors:  J A Douglass; D V Tuxen; M Horne; C D Scheinkestel; M Weinmann; D Czarny; G Bowes
Journal:  Am Rev Respir Dis       Date:  1992-08

Review 10.  Neuromuscular dysfunction acquired in critical illness: a systematic review.

Authors:  Robert D Stevens; David W Dowdy; Robert K Michaels; Pedro A Mendez-Tellez; Peter J Pronovost; Dale M Needham
Journal:  Intensive Care Med       Date:  2007-07-17       Impact factor: 17.440

View more
  7 in total

1.  Acute severe asthma: new approaches to assessment and treatment.

Authors:  Spyros A Papiris; Effrosyni D Manali; Likurgos Kolilekas; Christina Triantafillidou; Iraklis Tsangaris
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 2.  The incidence of intensive care unit-acquired weakness syndromes: A systematic review.

Authors:  Richard Td Appleton; John Kinsella; Tara Quasim
Journal:  J Intensive Care Soc       Date:  2014-12-18

Review 3.  Management of severe asthma exacerbation: guidelines from the Société Française de Médecine d'Urgence, the Société de Réanimation de Langue Française and the French Group for Pediatric Intensive Care and Emergencies.

Authors:  Philippe Le Conte; Nicolas Terzi; Guillaume Mortamet; Fekri Abroug; Guillaume Carteaux; Céline Charasse; Anthony Chauvin; Xavier Combes; Stéphane Dauger; Alexandre Demoule; Thibaut Desmettre; Stephan Ehrmann; Bénédicte Gaillard-Le Roux; Valérie Hamel; Boris Jung; Sabrina Kepka; Erwan L'Her; Mikaël Martinez; Christophe Milési; Élise Morawiec; Mathieu Oberlin; Patrick Plaisance; Robin Pouyau; Chantal Raherison; Patrick Ray; Mathieu Schmidt; Arnaud W Thille; Jennifer Truchot; Guillaume Valdenaire; Julien Vaux; Damien Viglino; Guillaume Voiriot; Bénédicte Vrignaud; Sandrine Jean; Eric Mariotte; Pierre-Géraud Claret
Journal:  Ann Intensive Care       Date:  2019-10-10       Impact factor: 6.925

Review 4.  Use of Natural Products in Asthma Treatment.

Authors:  Lucas Amaral-Machado; Wógenes N Oliveira; Susiane S Moreira-Oliveira; Daniel T Pereira; Éverton N Alencar; Nicolas Tsapis; Eryvaldo Sócrates T Egito
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-13       Impact factor: 2.629

5.  Embelin Alleviates Severe Airway Inflammation in OVA-LPS-Induced Rat Model of Allergic Asthma.

Authors:  Shazalyana Azman; Mahendran Sekar; Suzana Wahidin; Siew Hua Gan; Jaishree Vaijanathappa; Srinivasa Reddy Bonam; Mallika Alvala; Pei Teng Lum; Vandana Thakur; Jayesh V Beladiya; Anita A Mehta
Journal:  J Asthma Allergy       Date:  2021-12-15

6.  Year in review in Intensive Care Medicine 2009: II. Neurology, cardiovascular, experimental, pharmacology and sedation, communication and teaching.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2010-01-28       Impact factor: 17.440

Review 7.  Neuromuscular blockade management in the critically Ill patient.

Authors:  J Ross Renew; Robert Ratzlaff; Vivian Hernandez-Torres; Sorin J Brull; Richard C Prielipp
Journal:  J Intensive Care       Date:  2020-05-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.